Skip to main content

Table 1 Demographic and clinical characteristics of the study population

From: Predicting progression to severe COVID-19 using the PAINT score

Characteristic All patients (n = 239) Without progression (n = 216) Progression to severe (n = 23) p value
Sex Male n (%) 139 (58.2) 130 (60.2) 9 (39.1) 0.038
Age (year) 58 (26–90) 57.5 (26–88) 62 (29–90) 0.010
Max temperature (℃) 38.0 (36.0–41.0) 38.0 (36.0–39.8) 38.3 (36.5–41.0) 0.129
Clinical manifestations, n (%)
 Fever 186 (77.8) 168 (77.8) 18 (78.3) 0.688
 Cough 144 (60.3) 127 (58.8) 17 (73.9) 0.175
 Expectoration 57 (23.8) 50 (23.1) 7 (30.4) 0.642
 Dyspnea 25 (10.5) 23 (10.7) 2 (8.7) 0.001
 Chest pain 11 (4.6) 10 (4.6) 1 (4.3) 0.982
 Angina 10 (4.2) 8 (3.7) 2 (8.7) 0.662
 Fatigue 68 (28.5) 58 (26.9) 10 (43.5) 0.206
 Myalgia 22 (9.2) 22 (10.2) 0 0.221
 Headache 12 (5.0) 12 (5.6) 0 0.476
 Vomit 4 (1.7) 3 (1.4) 1 (4.3) 0.421
 Diarrhea 43 (18.0) 40 (18.5) 3 (13.0) 0.787
Comorbidities, n (%)
 Hypertension 66 (27.6) 60 (27.8) 6 (26.1) 0.782
 Diabetes mellitus 25 (10.5) 20 (9.3) 5 (21.7) 0.285
 Cardiac disease 20 (8.4) 19 (8.8) 1 (4.3) 0.509
 Pulmonary disease 10 (4.2) 7 (3.2) 3 (13.0) 0.035
 Liver disease 11 (4.6) 8 (3.7) 3 (13.0) 0.027